1.
Trends Microbiol
; 17(10): 439-43, 2009 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19758804
RESUMO
The market for N-glycosylated therapeutic proteins represents multi-billion dollars in sales and is growing more than 10% each year. This requires cost-effective production platforms that display correct and homogeneous N-glycosylation. Based on recent results, we propose to use mushroom-forming basidiomycetes for the production of N-glycosylated therapeutic proteins.